Pepto bismol mechanism of action

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Pepto Bismol Mechanism of Action: Bismuth Subsalicylate and Gastrointestinal Protection

Gastric Mucosal Protection and Coating Effect

Pepto Bismol, whose main active ingredient is bismuth subsalicylate, has been shown to protect the stomach lining from damage caused by stress, aspirin, and alcohol. This protective effect is likely related to the ability of Pepto Bismol to coat the gastric mucosa, forming a barrier that shields the tissue from irritants and harmful agents.

Chemical Structure and Hydrolysis

The exact mechanism of action of bismuth subsalicylate is not fully understood, but research into its chemical structure reveals that it forms complex bismuth oxosalicylate clusters. These clusters may play a role in how the drug interacts with the stomach lining and exerts its protective effects.

Conversion in the Gastrointestinal Tract

Once ingested, bismuth subsalicylate is broken down in the gastrointestinal tract into salicylic acid and insoluble bismuth salts. The salicylate component is mostly absorbed and excreted in urine, while very little bismuth is absorbed into the bloodstream. This breakdown process is important for both the drug’s effectiveness and its safety profile.

Antisecretory and Anti-Inflammatory Properties

Pepto Bismol has strong antisecretory properties, meaning it can reduce the amount of fluid secreted into the intestines in response to bacterial toxins such as those from E. coli and Vibrio cholerae. It also has anti-inflammatory effects, helping to reduce fluid accumulation and inflammation in the intestines, which is especially useful in treating diarrhea caused by infections or inflammation.

Antimicrobial and Antifermentative Effects

Pepto Bismol can reduce the fermentative activity of intestinal bacteria, which helps control excessive gas production and flatulence. This antifermentative action is likely due to the bismuth component, which can interfere with bacterial metabolism in the gut.

Conclusion

Pepto Bismol works through several mechanisms: it coats and protects the stomach lining, is broken down into active components that are safely processed by the body, reduces intestinal fluid secretion and inflammation, and limits bacterial fermentation in the gut. These combined actions make it effective for treating a range of gastrointestinal symptoms, including upset stomach, diarrhea, and gas12345.

Sources and full results

Most relevant research papers on this topic

Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats.

Pepto-Bismol liquid effectively protects rats' gastric mucosa from hemorrhagic lesions and erosions caused by cold, aspirin, and ethyl alcohol.

1975·

26citations

·M. Goldenberg et al.

Towards a structural understanding of the anti-ulcer and anti-gastritis drug bismuth subsalicylate.

The anti-ulcer and anti-gastritis drug bismuth subsalicylate (BSS) has a unique structure, with two bismuth oxosalicylate clusters providing structural insight into its nature.

Highly Cited

2006·

119citations

·P. Andrews et al.

Bismuth subsalicylate: history, chemistry, and safety.

Pepto-Bismol is a safe and effective treatment for acute conditions and extended dosing periods, with minimal bismuth absorption and low salicylate toxicity.

Highly Cited

1990·

132citations

·D. Bierer

Antisecretory and antiinflammatory properties of bismuth subsalicylate.

Bismuth subsalicylate, the active ingredient in Pepto-Bismol, effectively inhibits fluid accumulation in the intestine during infection with bacteria or toxins, with synergistic effects in preventing cholera toxin-induced fluid accumulation.

Non-RCTAnimal Study

1990·

39citations

·C. Ericsson et al.

[In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].

Bismuth-containing pharmaceutical preparations De Nol and Pepto Bismol significantly reduce intestinal fermentation, potentially aiding in the control of excessive intestinal fermentation and flatulence.

In Vitro Study

1985·

0citations

·R. León-Barúa et al.

Pharmacology of Bismuth-Containing Medicines Used to Treat Helicobacter pylori Infections

Bismuth-containing medicines effectively treat Helicobacter pylori infections, with their anti-microbial action and effects on the pathogenic mechanisms of H. pylori being studied in recent years.

1994·

2citations

·D. Hall

Interaction of Bismuth Subsalicylate with Fruit Juices, Ascorbic Acid, and Thiol-Containing Substrates To Produce Soluble Bismuth Products Active against Clostridium difficile

Bismuth subsalicylate, the active ingredient in Pepto-Bismol, interacts with fruit juices, ascorbic acid, and thiol-containing substrates to produce water-soluble products with activity against Clostridium difficile.

2005·

16citations

·D. E. Mahony et al.

In Vitro bile acid adsorption by bismuth subsalicylate and montmorillonite

Pepto-Bismol and Veegum effectively sequester bile acids in vitro, with Pepto-Bismol having a sequestering capacity similar to cholestyramine.

In Vitro Study

1984·

3citations

·S. Kocoshis et al.

Salicylate absorption from a bismuth subsalicylate preparation

Pepto-Bismol effectively absorbs salicylate, with peak plasma levels reached 0.5 to 3 hours after ingestion, and a linear relationship between dose and recovery in urine.

Non-RCT

1981·

29citations

·S. Feldman et al.

Post‐streptococcal nonallergic urticaria?

Anaphylaxis to Pepto-Bismol, a common NSAID, can occur in patients with nonallergic sensitization, indicating the need for further investigation into this potential drug allergy.

Case Report

2002·

5citations

·L. Bonanni et al.

Try another search

cbd adverse effects

temperature perception definition

rainfall prediction in western Africa using machine learning

hydrocodone acetaminophen pharmacology

gene editing therapies for sickle cell disease

PCSK9 inhibitors cost effectiveness